Evidence map›Paper›PMID 32363924›Full record

ArticleCell transplantation

Daniele Spinozzi, Alina Miron, Jessica T Lie, Mehrdad Rafat, Neil Lagali, Gerrit R J Melles, Sorcha Ni Dhubhghaill, Isabel Dapena, Silke Oellerich

Open access · goldAbstract read
In one paragraph

Article in Cell transplantation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Daniele SpinozziNetherlands Institute for Innovative Ocular Surgery, Rotterdam, the Netherlands.
Alina MironNetherlands Institute for Innovative Ocular Surgery, Rotterdam, the Netherlands.
Jessica T LieNetherlands Institute for Innovative Ocular Surgery, Rotterdam, the Netherlands.
Mehrdad RafatDepartment of Biomedical Engineering, Linköping University, Sweden.
Neil LagaliDivision of Ophthalmology, Department of Clinical and Experimental Medicine, Linköping University, Sweden.
Gerrit R J MellesNetherlands Institute for Innovative Ocular Surgery, Rotterdam, the Netherlands.
Sorcha Ni DhubhghaillNetherlands Institute for Innovative Ocular Surgery, Rotterdam, the Netherlands.
Isabel DapenaNetherlands Institute for Innovative Ocular Surgery, Rotterdam, the Netherlands.
Silke OellerichNetherlands Institute for Innovative Ocular Surgery, Rotterdam, the Netherlands.ORCID 0000-0002-5703-5971
Netherlands Institute for Innovative Ocular Surgery · NLLinköping University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Corneal transplantation is currently the only effective treatment option for dysfunctional corneal endothelial cells (CEC). In this study, we test

Indexed as

AgedAged, 80 and overCells, CulturedCorneal TransplantationEndothelial CellsHumansMiddle AgedTissue Engineeringcell carriercell culturecorneal transplantationDMEKdonor materialendothelial cell transplantation

Identifiers

PMID32363924
PMCPMC7586272
OpenAlexW3021429255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.